161 related articles for article (PubMed ID: 17163660)
1. Cholesterol, it's not just for heart disease anymore.
Kerzmann A; Feig AL
ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
3. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
4. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.
al-Barrak A; Embil J; Dyck B; Olekson K; Nicoll D; Alfa M; Kabani A
Can Commun Dis Rep; 1999 Apr; 25(7):65-9. PubMed ID: 10344088
[No Abstract] [Full Text] [Related]
5. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
[TBL] [Abstract][Full Text] [Related]
6. Outbreak from a high-toxin intruder: Clostridium difficile.
Norén T
Lancet; 2005 Sep 24-30; 366(9491):1053-4. PubMed ID: 16182878
[No Abstract] [Full Text] [Related]
7. Importance of culture for detection of Clostridium difficile toxin from stool samples to report true incidence and mortality related to C. difficile in hospitals.
Bayardelle P
Clin Infect Dis; 2009 Oct; 49(7):1134-5; author reply 1135. PubMed ID: 19739961
[No Abstract] [Full Text] [Related]
8. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
10. [Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?].
Reichardt C; Chaberny IF; Kola A; Mattner F; Vonberg RP; Gastmeier P
Dtsch Med Wochenschr; 2007 Feb; 132(5):223-8. PubMed ID: 17252365
[No Abstract] [Full Text] [Related]
11. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
[No Abstract] [Full Text] [Related]
12. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
Ruby R; Magdesian KG; Kass PH
J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of toxin A negative/B positive Clostridium difficile strains.
Brazier JS; Stubbs SL; Duerden BI
J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
[No Abstract] [Full Text] [Related]
15. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea.
Flemming K; Ackermann G
Infection; 2007 Oct; 35(5):356-8. PubMed ID: 17721737
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile toxins: mechanism of action and role in disease.
Voth DE; Ballard JD
Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
[TBL] [Abstract][Full Text] [Related]
18. New trends in Clostridium difficile virulence and pathogenesis.
Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
[TBL] [Abstract][Full Text] [Related]
19. Implications of the changing face of Clostridium difficile disease for health care practitioners.
McFarland LV; Beneda HW; Clarridge JE; Raugi GJ
Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995
[TBL] [Abstract][Full Text] [Related]
20. [Molecular epidemiology and laboratory diagnosis of Clostridium difficile-associated diarrhea].
Kato H
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 14(2):121-6. PubMed ID: 15552833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
